Global DNA 5‐Hydroxymethylcytosine and 5‐Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma

Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5‐hydroxymethylcytosine (5hmC), 5‐formylcytosine (5fC), and 5‐carboxylcytosine (5caC), are in dynamic existence and have distinct regulat...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 69; no. 1; pp. 196 - 208
Main Authors Liu, Jiao, Jiang, Jinhua, Mo, Jiezhen, Liu, Dan, Cao, Dan, Wang, Hailin, He, Yufei, Wang, Hongyang
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5‐hydroxymethylcytosine (5hmC), 5‐formylcytosine (5fC), and 5‐carboxylcytosine (5caC), are in dynamic existence and have distinct regulatory functions. In the current study, we investigated whether there are changes in the contents of all three 5mC‐oxidized derivatives in the hepatocellular carcinoma (HCC) genome and further explored the underlying mechanisms. We showed that both global genomic 5hmC and 5fC contents were decreased significantly in the very early stage (stage 0, Barcelona Clinic Liver Cancer [BCLC] staging) of HCC compared with those of paratumor tissues. Noteworthily, 5fC content continued to decrease in the late stage (BCLC staging from 0 to A) of HCC. The 5caC content in HCC tissues was below the detection threshold. Hepatitis B virus (HBV) infection was associated with 5mC, 5hmC, or 5fC decrease in HCC; and measurements in cell lines integrated with or without HBV DNA showed consistent results. On the other hand, both the expression level of ten‐eleven translocation enzyme 2 (TET2) and α‐ketoglutarate content were decreased significantly in HCC. The significantly positive correlations among the expression levels of DNA methylation–related enzymes in paratumor tissues were generally attenuated or even disappeared in HCC tumor tissues. The decreases of both 5hmC and 5fC contents in genomic DNA were associated with poor prognosis of HCC patients. Conclusion: Global 5hmC and 5fC contents were decreased significantly in the very early stage of HCC; the decrease of 5hmC and 5fC was mainly due to the decrease of 5mC and associated with HBV infection, decreased TET enzyme activity, and uncoordinated expression of DNA methylation–related enzymes.
AbstractList Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5‐hydroxymethylcytosine (5hmC), 5‐formylcytosine (5fC), and 5‐carboxylcytosine (5caC), are in dynamic existence and have distinct regulatory functions. In the current study, we investigated whether there are changes in the contents of all three 5mC‐oxidized derivatives in the hepatocellular carcinoma (HCC) genome and further explored the underlying mechanisms. We showed that both global genomic 5hmC and 5fC contents were decreased significantly in the very early stage (stage 0, Barcelona Clinic Liver Cancer [BCLC] staging) of HCC compared with those of paratumor tissues. Noteworthily, 5fC content continued to decrease in the late stage (BCLC staging from 0 to A) of HCC. The 5caC content in HCC tissues was below the detection threshold. Hepatitis B virus (HBV) infection was associated with 5mC, 5hmC, or 5fC decrease in HCC; and measurements in cell lines integrated with or without HBV DNA showed consistent results. On the other hand, both the expression level of ten‐eleven translocation enzyme 2 (TET2) and α‐ketoglutarate content were decreased significantly in HCC. The significantly positive correlations among the expression levels of DNA methylation–related enzymes in paratumor tissues were generally attenuated or even disappeared in HCC tumor tissues. The decreases of both 5hmC and 5fC contents in genomic DNA were associated with poor prognosis of HCC patients. Conclusion: Global 5hmC and 5fC contents were decreased significantly in the very early stage of HCC; the decrease of 5hmC and 5fC was mainly due to the decrease of 5mC and associated with HBV infection, decreased TET enzyme activity, and uncoordinated expression of DNA methylation–related enzymes.
Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), are in dynamic existence and have distinct regulatory functions. In the current study, we investigated whether there are changes in the contents of all three 5mC-oxidized derivatives in the hepatocellular carcinoma (HCC) genome and further explored the underlying mechanisms. We showed that both global genomic 5hmC and 5fC contents were decreased significantly in the very early stage (stage 0, Barcelona Clinic Liver Cancer [BCLC] staging) of HCC compared with those of paratumor tissues. Noteworthily, 5fC content continued to decrease in the late stage (BCLC staging from 0 to A) of HCC. The 5caC content in HCC tissues was below the detection threshold. Hepatitis B virus (HBV) infection was associated with 5mC, 5hmC, or 5fC decrease in HCC; and measurements in cell lines integrated with or without HBV DNA showed consistent results. On the other hand, both the expression level of ten-eleven translocation enzyme 2 (TET2) and α-ketoglutarate content were decreased significantly in HCC. The significantly positive correlations among the expression levels of DNA methylation-related enzymes in paratumor tissues were generally attenuated or even disappeared in HCC tumor tissues. The decreases of both 5hmC and 5fC contents in genomic DNA were associated with poor prognosis of HCC patients. Conclusion: Global 5hmC and 5fC contents were decreased significantly in the very early stage of HCC; the decrease of 5hmC and 5fC was mainly due to the decrease of 5mC and associated with HBV infection, decreased TET enzyme activity, and uncoordinated expression of DNA methylation-related enzymes.Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC, namely 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC), are in dynamic existence and have distinct regulatory functions. In the current study, we investigated whether there are changes in the contents of all three 5mC-oxidized derivatives in the hepatocellular carcinoma (HCC) genome and further explored the underlying mechanisms. We showed that both global genomic 5hmC and 5fC contents were decreased significantly in the very early stage (stage 0, Barcelona Clinic Liver Cancer [BCLC] staging) of HCC compared with those of paratumor tissues. Noteworthily, 5fC content continued to decrease in the late stage (BCLC staging from 0 to A) of HCC. The 5caC content in HCC tissues was below the detection threshold. Hepatitis B virus (HBV) infection was associated with 5mC, 5hmC, or 5fC decrease in HCC; and measurements in cell lines integrated with or without HBV DNA showed consistent results. On the other hand, both the expression level of ten-eleven translocation enzyme 2 (TET2) and α-ketoglutarate content were decreased significantly in HCC. The significantly positive correlations among the expression levels of DNA methylation-related enzymes in paratumor tissues were generally attenuated or even disappeared in HCC tumor tissues. The decreases of both 5hmC and 5fC contents in genomic DNA were associated with poor prognosis of HCC patients. Conclusion: Global 5hmC and 5fC contents were decreased significantly in the very early stage of HCC; the decrease of 5hmC and 5fC was mainly due to the decrease of 5mC and associated with HBV infection, decreased TET enzyme activity, and uncoordinated expression of DNA methylation-related enzymes.
Author Wang, Hongyang
Wang, Hailin
Liu, Jiao
Mo, Jiezhen
Jiang, Jinhua
Cao, Dan
He, Yufei
Liu, Dan
Author_xml – sequence: 1
  givenname: Jiao
  surname: Liu
  fullname: Liu, Jiao
  organization: Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine
– sequence: 2
  givenname: Jinhua
  surname: Jiang
  fullname: Jiang, Jinhua
  organization: Eastern Hepatobiliary Surgery Institute/Hospital
– sequence: 3
  givenname: Jiezhen
  surname: Mo
  fullname: Mo, Jiezhen
  organization: Research Center for Eco‐Environmental Sciences, Chinese Academy of Sciences
– sequence: 4
  givenname: Dan
  surname: Liu
  fullname: Liu, Dan
  organization: Model Animal Research Center of Nanjing University
– sequence: 5
  givenname: Dan
  surname: Cao
  fullname: Cao, Dan
  organization: Eastern Hepatobiliary Surgery Institute/Hospital
– sequence: 6
  givenname: Hailin
  surname: Wang
  fullname: Wang, Hailin
  email: hlwang@rcees.ac.cn
  organization: Research Center for Eco‐Environmental Sciences, Chinese Academy of Sciences
– sequence: 7
  givenname: Yufei
  surname: He
  fullname: He, Yufei
  email: yfhe@sibcb.ac.cn
  organization: Eastern Hepatobiliary Surgery Hospital
– sequence: 8
  givenname: Hongyang
  surname: Wang
  fullname: Wang, Hongyang
  email: hywangk@vip.sina.com
  organization: Model Animal Research Center of Nanjing University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30070373$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFu1DAQhi1URLeFAy-ALHGBw7ZjO4nXx9V220WqAAk4W048YVM59mI7KrnBG_CMPAlpdyuhCk4jzXz_r9H_n5AjHzwS8pLBGQPg51vcnQlgRfWEzFjJ5VyIEo7IDLiEuWJCHZOTlG4AQBV88YwcCwAJQooZ-XnlQm0cvXi_pOXvH782o43h-9hj3o6uGXNInUdqvL2_XobY_7VeBZ_R50SXEekFNhFNQks7T_MW6dpEN9JP2XxFGlq6wZ3JoUHnBmciXZnYdD705jl52hqX8MVhnpIvl-vPq838-sPVu9Xyet4UTFXzshbYilrIlnHGKyVLaduqbtFYW6vSWlwYIWzNC8GbRnGQCqsKlJAGkbWtOCVv9r67GL4NmLLuu3T3jvEYhqQ5LDgoXoCc0NeP0JswRD99pzmrioKXSiwm6tWBGuoerd7Frjdx1A_hTsD5HmhiSCliq5sum9xNqUXTOc1A39Wnp_r0fX2T4u0jxYPpv9iD-23ncPw_qDfrj3vFHxt-q34
CitedBy_id crossref_primary_10_3389_fcell_2021_744990
crossref_primary_10_1016_j_yexcr_2023_113563
crossref_primary_10_1016_j_jbc_2022_102095
crossref_primary_10_1111_hepr_13250
crossref_primary_10_3390_cells13040298
crossref_primary_10_3389_fphar_2024_1418456
crossref_primary_10_3389_fonc_2022_911715
crossref_primary_10_1038_s41419_022_05450_z
crossref_primary_10_1016_j_biosx_2021_100104
crossref_primary_10_1002_jmv_29634
crossref_primary_10_1155_2022_4835417
crossref_primary_10_1021_acschembio_3c00247
crossref_primary_10_12688_wellcomeopenres_14839_1
crossref_primary_10_3390_molecules27207041
crossref_primary_10_1016_j_mrgentox_2024_503755
crossref_primary_10_3390_jcm9030734
crossref_primary_10_1016_j_ctrv_2024_102763
crossref_primary_10_1038_s41598_020_64700_2
crossref_primary_10_3389_fcell_2020_00004
crossref_primary_10_3390_curroncol28050321
crossref_primary_10_3390_ijms22189858
crossref_primary_10_1016_j_jhepr_2020_100167
crossref_primary_10_1002_wsbm_1598
crossref_primary_10_3390_jcm10081715
crossref_primary_10_3390_ijerph16152791
crossref_primary_10_1242_bio_043687
crossref_primary_10_3389_fonc_2022_856707
crossref_primary_10_3389_fimmu_2023_1148722
crossref_primary_10_1016_j_cclet_2022_05_050
crossref_primary_10_1016_j_talanta_2022_123421
crossref_primary_10_3390_ijms24054964
crossref_primary_10_1186_s13148_022_01323_6
crossref_primary_10_1007_s10620_024_08311_1
crossref_primary_10_1007_s00018_022_04396_x
crossref_primary_10_1002_ctm2_70066
crossref_primary_10_1186_s13148_022_01344_1
crossref_primary_10_1016_j_hbpd_2023_02_011
crossref_primary_10_1016_j_cmet_2020_10_021
crossref_primary_10_1186_s40364_022_00402_3
crossref_primary_10_3389_fgene_2020_00171
crossref_primary_10_1186_s13148_024_01726_7
crossref_primary_10_1002_med_21696
crossref_primary_10_1002_mas_21865
crossref_primary_10_1016_j_bios_2024_116547
crossref_primary_10_1016_j_celrep_2020_03_039
crossref_primary_10_1155_2023_5449443
crossref_primary_10_3389_fonc_2021_681781
crossref_primary_10_1002_hep_32062
crossref_primary_10_3389_fcell_2022_810687
crossref_primary_10_1186_s13052_020_00877_6
crossref_primary_10_1021_acs_analchem_9b05715
crossref_primary_10_1097_MD_0000000000020326
crossref_primary_10_1002_adhm_202101193
crossref_primary_10_2147_JHC_S458734
crossref_primary_10_3389_fcell_2024_1489836
crossref_primary_10_1111_jvh_14044
crossref_primary_10_1080_15592294_2019_1700004
crossref_primary_10_1111_cpr_12626
crossref_primary_10_1289_EHP5862
crossref_primary_10_3389_fgene_2021_772298
crossref_primary_10_1021_acs_analchem_0c03201
crossref_primary_10_1007_s12022_024_09800_9
crossref_primary_10_3233_CBM_210485
crossref_primary_10_1021_acssensors_4c03312
crossref_primary_10_1038_s41419_022_05406_3
crossref_primary_10_1016_j_cjac_2022_100093
crossref_primary_10_1021_acs_analchem_1c04151
crossref_primary_10_1021_acs_analchem_4c01446
crossref_primary_10_1016_j_aca_2019_07_002
crossref_primary_10_1016_j_trac_2023_117306
crossref_primary_10_1038_s41467_023_43743_9
crossref_primary_10_1021_acs_analchem_0c00962
crossref_primary_10_1038_s41421_022_00399_x
crossref_primary_10_1186_s13148_020_00898_2
Cites_doi 10.1093/carcin/bgn111
10.1038/nrgastro.2015.152
10.1158/0008-5472.CAN-15-3278
10.1016/j.cell.2013.04.001
10.1038/nature12052
10.1021/ja4028346
10.1053/jhep.2001.22507
10.1038/nchembio.914
10.1126/science.1170116
10.1016/j.jhep.2016.02.021
10.1038/nchembio.2531
10.1038/nrg.2016.83
10.1136/gutjnl-2015-311292
10.1016/j.jhep.2017.09.016
10.1073/pnas.84.4.1005
10.1073/pnas.1400604111
10.1038/onc.2012.67
10.1016/j.cell.2013.02.004
10.1053/j.gastro.2007.01.034
10.2217/epi-2016-0027
10.1186/s13059-016-1001-5
10.1002/hep.27406
10.1016/S0140-6736(11)61347-0
10.1038/nchembio.1848
10.1021/ac3034695
10.1002/hep.23660
10.1038/nrg1655
10.1158/0008-5472.CAN-11-2023
10.1016/j.cell.2012.07.033
10.1038/nsmb.3071
10.1038/nbt.2931
10.1016/j.ccr.2010.12.014
10.1038/nsmb.2346
10.1126/science.1210944
10.1016/j.cell.2013.12.019
10.1186/gb-2013-14-10-r119
10.1101/gad.276568.115
10.1126/science.1210597
10.1038/nchem.2064
10.1053/j.gastro.2015.12.041
10.1002/hep.27823
10.1002/hep.27969
10.1146/annurev.pathol.3.121806.151442
10.1038/cr.2014.81
10.1186/s13072-017-0170-0
ContentType Journal Article
Copyright 2018 by the American Association for the Study of Liver Diseases.
2019 by the American Association for the Study of Liver Diseases.
Copyright_xml – notice: 2018 by the American Association for the Study of Liver Diseases.
– notice: 2019 by the American Association for the Study of Liver Diseases.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
DOI 10.1002/hep.30146
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 208
ExternalDocumentID 30070373
10_1002_hep_30146
HEP30146
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 81521091; 91743201
– fundername: Ministry of Education
  funderid: 2017ZZ01007; XDB14030200; 2018ZX10723204
– fundername: Chinese Academy of Sciences
– fundername: National Natural Science Foundation of China
  grantid: 91743201
– fundername: National Natural Science Foundation of China
  grantid: 81521091
– fundername: Ministry of Education
  grantid: XDB14030200
– fundername: National Science and Technology Major Project of China
  grantid: 2018ZX10723204
– fundername: Most Important Clinical Medical Center in Shanghai
  grantid: 2017ZZ01007
– fundername: Ministry of Education Key Laboratory on Signaling Regulation and Targeting Therapy of Liver Cancer
– fundername: Strategic Priority Research Program of the Chinese Academy of Sciences
  grantid: XDB14030200
– fundername: Ministry of Education
  grantid: 2017ZZ01007
– fundername: Ministry of Education
  grantid: 2018ZX10723204
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AANHP
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACLDA
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ABJNI
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
AAMMB
ADSXY
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c4196-5b3ef3b37f121269757df6bfeaddb95dde8a33db2432cc92079e660937aee1ff3
IEDL.DBID DR2
ISSN 0270-9139
1527-3350
IngestDate Tue Aug 05 09:51:21 EDT 2025
Wed Aug 13 09:01:43 EDT 2025
Thu Apr 03 06:59:35 EDT 2025
Tue Jul 01 05:14:08 EDT 2025
Thu Apr 24 23:10:11 EDT 2025
Wed Jan 22 16:44:11 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2018 by the American Association for the Study of Liver Diseases.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4196-5b3ef3b37f121269757df6bfeaddb95dde8a33db2432cc92079e660937aee1ff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 30070373
PQID 2164425938
PQPubID 996352
PageCount 0
ParticipantIDs proquest_miscellaneous_2082092407
proquest_journals_2164425938
pubmed_primary_30070373
crossref_citationtrail_10_1002_hep_30146
crossref_primary_10_1002_hep_30146
wiley_primary_10_1002_hep_30146_HEP30146
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2019
2019-01-00
20190101
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: January 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2019
Publisher Wolters Kluwer Health, Inc
Publisher_xml – name: Wolters Kluwer Health, Inc
References 2015; 12
2011; 333
2015; 11
2013; 85
2016; 76
2016; 30
2012; 19
2014; 24
2016; 17
2014; 111
2011; 19
2014; 60
2014; 156
2003; 33
2018; 68
2012; 150
2013; 14
1987; 84
2013; 32
2015; 62
2011; 71
2008; 29
2007; 132
2017; 10
2015; 22
2018; 412
2016; 65
2013; 497
2016; 64
2005; 6
2013; 135
2013; 152
2009; 4
2013; 153
2001; 33
2012; 379
2014; 6
2016; 8
2010; 52
2009; 324
2018; 14
2012; 8
2014; 32
2016; 150
(hep30146-bib-0009-20250401) 2012; 150
(hep30146-bib-0028-20250401) 2014; 60
(hep30146-bib-0015-20250401) 2014; 6
(hep30146-bib-0043-20250401) 2014; 32
(hep30146-bib-0044-20250401) 2001; 33
(hep30146-bib-0003-20250401) 2016; 76
(hep30146-bib-0041-20250401) 2011; 19
(hep30146-bib-0033-20250401) 2013; 85
(hep30146-bib-0020-20250401) 2013; 152
(hep30146-bib-0007-20250401) 2016; 30
(hep30146-bib-0026-20250401) 2015; 62
(hep30146-bib-0010-20250401) 2011; 333
(hep30146-bib-0040-20250401) 2014; 24
(hep30146-bib-0030-20250401) 2016; 65
(hep30146-bib-0001-20250401) 2005; 6
(hep30146-bib-0005-20250401) 2009; 324
(hep30146-bib-0019-20250401) 2013; 14
(hep30146-bib-0025-20250401) 2018; 68
(hep30146-bib-0038-20250401) 2013; 497
(hep30146-bib-0006-20250401) 2011; 71
(hep30146-bib-0004-20250401) 2014; 156
(hep30146-bib-0045-20250401) 2014; 111
(hep30146-bib-0036-20250401) 1987; 84
(hep30146-bib-0042-20250401) 2017; 10
(hep30146-bib-0008-20250401) 2013; 32
(hep30146-bib-0014-20250401) 2015; 22
(hep30146-bib-0021-20250401) 2016; 17
(hep30146-bib-0035-20250401) 2015; 62
(hep30146-bib-0013-20250401) 2012; 8
(hep30146-bib-0012-20250401) 2018; 14
(hep30146-bib-0022-20250401) 2012; 19
(hep30146-bib-0018-20250401) 2016; 17
(hep30146-bib-0027-20250401) 2018; 412
(hep30146-bib-0031-20250401) 2015; 12
(hep30146-bib-0023-20250401) 2016; 150
(hep30146-bib-0037-20250401) 2008; 29
(hep30146-bib-0024-20250401) 2012; 379
(hep30146-bib-0032-20250401) 2016; 8
(hep30146-bib-0017-20250401) 2013; 153
(hep30146-bib-0016-20250401) 2015; 11
(hep30146-bib-0029-20250401) 2016; 64
(hep30146-bib-0046-20250401) 2007; 132
(hep30146-bib-0047-20250401) 2010; 52
(hep30146-bib-0002-20250401) 2009; 4
(hep30146-bib-0034-20250401) 2013; 135
(hep30146-bib-0011-20250401) 2011; 333
(hep30146-bib-0039-20250401) 2003; 33
References_xml – volume: 30
  start-page: 733
  year: 2016
  end-page: 750
  article-title: Role of TET enzymes in DNA methylation, development, and cancer
  publication-title: Genes Dev
– volume: 6
  start-page: 1049
  year: 2014
  end-page: 1055
  article-title: 5‐Hydroxymethylcytosine is a predominantly stable DNA modification
  publication-title: Nat Chem
– volume: 8
  start-page: 993
  year: 2016
  end-page: 1005
  article-title: Interplay of genetic and epigenetic alterations in hepatocellular carcinoma
  publication-title: Epigenomics
– volume: 65
  start-page: 1895
  year: 2016
  end-page: 1905
  article-title: Epigenetics in liver disease: from biology to therapeutics
  publication-title: Gut
– volume: 132
  start-page: 1476
  year: 2007
  end-page: 1494
  article-title: Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein
  publication-title: Gastroenterology
– volume: 497
  start-page: 122
  year: 2013
  end-page: 126
  article-title: Modulation of TET2 expression and 5‐methylcytosine oxidation by the CXXC domain protein IDAX
  publication-title: Nature
– volume: 324
  start-page: 930
  year: 2009
  end-page: 935
  article-title: Conversion of 5‐methylcytosine to 5‐hydroxymethylcytosine in mammalian DNA by MLL partner TET1
  publication-title: Science
– volume: 11
  start-page: 555
  year: 2015
  end-page: 557
  article-title: 5‐Formylcytosine can be a stable DNA modification in mammals
  publication-title: Nat Chem Biol
– volume: 14
  start-page: 72
  year: 2018
  end-page: 78
  article-title: 5‐Formylcytosine to cytosine conversion by C‐C bond cleavage
  publication-title: Nat Chem Biol
– volume: 62
  start-page: 496
  year: 2015
  end-page: 504
  article-title: Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate
  publication-title: Hepatology
– volume: 333
  start-page: 1300
  year: 2011
  end-page: 1303
  article-title: Tet proteins can convert 5‐methylcytosine to 5‐formylcytosine and 5‐carboxylcytosine
  publication-title: Science
– volume: 32
  start-page: 896
  year: 2014
  end-page: 902
  article-title: Normalization of RNA‐seq data using factor analysis of control genes or samples
  publication-title: Nat Biotechnol
– volume: 29
  start-page: 1207
  year: 2008
  end-page: 1214
  article-title: Mutations in the C‐terminus of the X protein of hepatitis B virus regulate Wnt‐5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses
  publication-title: Carcinogenesis
– volume: 10
  start-page: 61
  year: 2017
  article-title: Uncoordinated expression of DNA methylation–related enzymes in human cancer
  publication-title: Epigenetics Chromatin
– volume: 22
  start-page: 656
  year: 2015
  end-page: 661
  article-title: Charting oxidized methylcytosines at base resolution
  publication-title: Nat Struct Mol Biol
– volume: 19
  start-page: 831
  year: 2012
  end-page: 833
  article-title: 5‐Formylcytosine and 5‐carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription
  publication-title: Nat Struct Mol Biol
– volume: 153
  start-page: 678
  year: 2013
  end-page: 691
  article-title: Genome‐wide profiling of 5‐formylcytosine reveals its roles in epigenetic priming
  publication-title: Cell
– volume: 33
  start-page: 245
  issue: Suppl.
  year: 2003
  end-page: 254
  article-title: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
  publication-title: Nat Genet
– volume: 8
  start-page: 328
  year: 2012
  end-page: 330
  article-title: Thymine DNA glycosylase specifically recognizes 5‐carboxylcytosine‐modified DNA
  publication-title: Nat Chem Biol
– volume: 68
  start-page: 526
  year: 2018
  end-page: 549
  article-title: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
  publication-title: J Hepatol
– volume: 24
  start-page: 1017
  year: 2014
  end-page: 1020
  article-title: TET‐catalyzed 5‐methylcytosine hydroxylation is dynamically regulated by metabolites
  publication-title: Cell Res
– volume: 17
  start-page: 141
  year: 2016
  article-title: genome‐wide profiling reveals a tissue‐specific role for 5‐formylcytosine
  publication-title: Genome Biol
– volume: 12
  start-page: 558
  year: 2015
  end-page: 559
  article-title: Hepatitis: epigenetic control of HBV by HBx protein—releasing the break?
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 33
  start-page: 561
  year: 2001
  end-page: 568
  article-title: Expression of mRNA for DNA methyltransferases and methyl‐CpG‐binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis
  publication-title: Hepatology
– volume: 156
  start-page: 45
  year: 2014
  end-page: 68
  article-title: Reversing DNA methylation: mechanisms, genomics, and biological functions
  publication-title: Cell
– volume: 14
  start-page: R119
  year: 2013
  article-title: A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation
  publication-title: Genome Biol
– volume: 62
  start-page: 1190
  year: 2015
  end-page: 1200
  article-title: World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
  publication-title: Hepatology
– volume: 85
  start-page: 3190
  year: 2013
  end-page: 3197
  article-title: An ammonium bicarbonate–enhanced stable isotope dilution UHPLC‐MS/MS method for sensitive and accurate quantification of acrolein‐DNA adducts in human leukocytes
  publication-title: Anal Chem
– volume: 71
  start-page: 7360
  year: 2011
  end-page: 7365
  article-title: 5‐Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations
  publication-title: Cancer Res
– volume: 333
  start-page: 1303
  year: 2011
  end-page: 1307
  article-title: Tet‐mediated formation of 5‐carboxylcytosine and its excision by TDG in mammalian DNA
  publication-title: Science
– volume: 17
  start-page: 551
  year: 2016
  end-page: 565
  article-title: Transcription factors as readers and effectors of DNA methylation
  publication-title: Nat Rev Genet
– volume: 379
  start-page: 1245
  year: 2012
  end-page: 1255
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
– volume: 64
  start-page: S84
  year: 2016
  end-page: S101
  article-title: Mechanisms of HBV‐induced hepatocellular carcinoma
  publication-title: J Hepatol
– volume: 412
  start-page: 283
  year: 2018
  end-page: 288
  article-title: Precision diagnosis and treatment of liver cancer in China
  publication-title: CancerLett
– volume: 135
  start-page: 10396
  year: 2013
  end-page: 10403
  article-title: Ascorbic acid enhances Tet‐mediated 5‐methylcytosine oxidation and promotes DNA demethylation in mammals
  publication-title: J Am Chem Soc
– volume: 4
  start-page: 229
  year: 2009
  end-page: 249
  article-title: Epigenetic changes in cancer
  publication-title: Annu Rev Pathol
– volume: 52
  start-page: 60
  year: 2010
  end-page: 70
  article-title: Down‐regulated microRNA‐152 induces aberrant DNA methylation in hepatitis B virus–related hepatocellular carcinoma by targeting DNA methyltransferase 1
  publication-title: Hepatology
– volume: 19
  start-page: 17
  year: 2011
  end-page: 30
  article-title: Oncometabolite 2‐hydroxyglutarate is a competitive inhibitor of alpha‐ketoglutarate‐dependent dioxygenases
  publication-title: Cancer Cell
– volume: 111
  start-page: 9555
  year: 2014
  end-page: 9560
  article-title: HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators
  publication-title: Proc Natl Acad Sci USA
– volume: 76
  start-page: 3446
  year: 2016
  end-page: 3450
  article-title: DNA methylation in cancer and aging
  publication-title: Cancer Res
– volume: 84
  start-page: 1005
  year: 1987
  end-page: 1009
  article-title: Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA
  publication-title: Proc Natl Acad Sci USA
– volume: 150
  start-page: 835
  year: 2016
  end-page: 853
  article-title: Evidence‐based diagnosis, staging, and treatment of patients with hepatocellular carcinoma
  publication-title: Gastroenterology
– volume: 150
  start-page: 1135
  year: 2012
  end-page: 1146
  article-title: Loss of 5‐hydroxymethylcytosine is an epigenetic hallmark of melanoma
  publication-title: Cell
– volume: 32
  start-page: 663
  year: 2013
  end-page: 669
  article-title: Tumor development is associated with decrease of TET gene expression and 5‐methylcytosine hydroxylation
  publication-title: Oncogene
– volume: 152
  start-page: 1146
  year: 2013
  end-page: 1159
  article-title: Dynamic readers for 5‐(hydroxy)methylcytosine and its oxidized derivatives
  publication-title: Cell
– volume: 60
  start-page: 2099
  year: 2014
  end-page: 2108
  article-title: The global burden of liver disease: the major impact of China
  publication-title: Hepatology
– volume: 6
  start-page: 597
  year: 2005
  end-page: 610
  article-title: DNA methylation and human disease
  publication-title: Nat Rev Genet
– volume: 29
  start-page: 1207
  year: 2008
  ident: hep30146-bib-0037-20250401
  article-title: Mutations in the C‐terminus of the X protein of hepatitis B virus regulate Wnt‐5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgn111
– volume: 12
  start-page: 558
  year: 2015
  ident: hep30146-bib-0031-20250401
  article-title: Hepatitis: epigenetic control of HBV by HBx protein—releasing the break?
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2015.152
– volume: 76
  start-page: 3446
  year: 2016
  ident: hep30146-bib-0003-20250401
  article-title: DNA methylation in cancer and aging
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-3278
– volume: 153
  start-page: 678
  year: 2013
  ident: hep30146-bib-0017-20250401
  article-title: Genome‐wide profiling of 5‐formylcytosine reveals its roles in epigenetic priming
  publication-title: Cell
  doi: 10.1016/j.cell.2013.04.001
– volume: 497
  start-page: 122
  year: 2013
  ident: hep30146-bib-0038-20250401
  article-title: Modulation of TET2 expression and 5‐methylcytosine oxidation by the CXXC domain protein IDAX
  publication-title: Nature
  doi: 10.1038/nature12052
– volume: 135
  start-page: 10396
  year: 2013
  ident: hep30146-bib-0034-20250401
  article-title: Ascorbic acid enhances Tet‐mediated 5‐methylcytosine oxidation and promotes DNA demethylation in mammals
  publication-title: J Am Chem Soc
  doi: 10.1021/ja4028346
– volume: 33
  start-page: 561
  year: 2001
  ident: hep30146-bib-0044-20250401
  article-title: Expression of mRNA for DNA methyltransferases and methyl‐CpG‐binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis
  publication-title: Hepatology
  doi: 10.1053/jhep.2001.22507
– volume: 8
  start-page: 328
  year: 2012
  ident: hep30146-bib-0013-20250401
  article-title: Thymine DNA glycosylase specifically recognizes 5‐carboxylcytosine‐modified DNA
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.914
– volume: 324
  start-page: 930
  year: 2009
  ident: hep30146-bib-0005-20250401
  article-title: Conversion of 5‐methylcytosine to 5‐hydroxymethylcytosine in mammalian DNA by MLL partner TET1
  publication-title: Science
  doi: 10.1126/science.1170116
– volume: 64
  start-page: S84
  year: 2016
  ident: hep30146-bib-0029-20250401
  article-title: Mechanisms of HBV‐induced hepatocellular carcinoma
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2016.02.021
– volume: 14
  start-page: 72
  year: 2018
  ident: hep30146-bib-0012-20250401
  article-title: 5‐Formylcytosine to cytosine conversion by C‐C bond cleavage in vivo
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.2531
– volume: 17
  start-page: 551
  year: 2016
  ident: hep30146-bib-0021-20250401
  article-title: Transcription factors as readers and effectors of DNA methylation
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg.2016.83
– volume: 65
  start-page: 1895
  year: 2016
  ident: hep30146-bib-0030-20250401
  article-title: Epigenetics in liver disease: from biology to therapeutics
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-311292
– volume: 68
  start-page: 526
  year: 2018
  ident: hep30146-bib-0025-20250401
  article-title: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.09.016
– volume: 84
  start-page: 1005
  year: 1987
  ident: hep30146-bib-0036-20250401
  article-title: Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.84.4.1005
– volume: 111
  start-page: 9555
  year: 2014
  ident: hep30146-bib-0045-20250401
  article-title: HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1400604111
– volume: 32
  start-page: 663
  year: 2013
  ident: hep30146-bib-0008-20250401
  article-title: Tumor development is associated with decrease of TET gene expression and 5‐methylcytosine hydroxylation
  publication-title: Oncogene
  doi: 10.1038/onc.2012.67
– volume: 152
  start-page: 1146
  year: 2013
  ident: hep30146-bib-0020-20250401
  article-title: Dynamic readers for 5‐(hydroxy)methylcytosine and its oxidized derivatives
  publication-title: Cell
  doi: 10.1016/j.cell.2013.02.004
– volume: 132
  start-page: 1476
  year: 2007
  ident: hep30146-bib-0046-20250401
  article-title: Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.01.034
– volume: 8
  start-page: 993
  year: 2016
  ident: hep30146-bib-0032-20250401
  article-title: Interplay of genetic and epigenetic alterations in hepatocellular carcinoma
  publication-title: Epigenomics
  doi: 10.2217/epi-2016-0027
– volume: 33
  start-page: 245
  issue: Suppl.
  year: 2003
  ident: hep30146-bib-0039-20250401
  article-title: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
  publication-title: Nat Genet
– volume: 17
  start-page: 141
  year: 2016
  ident: hep30146-bib-0018-20250401
  article-title: In vivo genome‐wide profiling reveals a tissue‐specific role for 5‐formylcytosine
  publication-title: Genome Biol
  doi: 10.1186/s13059-016-1001-5
– volume: 60
  start-page: 2099
  year: 2014
  ident: hep30146-bib-0028-20250401
  article-title: The global burden of liver disease: the major impact of China
  publication-title: Hepatology
  doi: 10.1002/hep.27406
– volume: 379
  start-page: 1245
  year: 2012
  ident: hep30146-bib-0024-20250401
  article-title: Hepatocellular carcinoma
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61347-0
– volume: 412
  start-page: 283
  year: 2018
  ident: hep30146-bib-0027-20250401
  article-title: Precision diagnosis and treatment of liver cancer in China
  publication-title: CancerLett
– volume: 11
  start-page: 555
  year: 2015
  ident: hep30146-bib-0016-20250401
  article-title: 5‐Formylcytosine can be a stable DNA modification in mammals
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.1848
– volume: 85
  start-page: 3190
  year: 2013
  ident: hep30146-bib-0033-20250401
  article-title: An ammonium bicarbonate–enhanced stable isotope dilution UHPLC‐MS/MS method for sensitive and accurate quantification of acrolein‐DNA adducts in human leukocytes
  publication-title: Anal Chem
  doi: 10.1021/ac3034695
– volume: 52
  start-page: 60
  year: 2010
  ident: hep30146-bib-0047-20250401
  article-title: Down‐regulated microRNA‐152 induces aberrant DNA methylation in hepatitis B virus–related hepatocellular carcinoma by targeting DNA methyltransferase 1
  publication-title: Hepatology
  doi: 10.1002/hep.23660
– volume: 6
  start-page: 597
  year: 2005
  ident: hep30146-bib-0001-20250401
  article-title: DNA methylation and human disease
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1655
– volume: 71
  start-page: 7360
  year: 2011
  ident: hep30146-bib-0006-20250401
  article-title: 5‐Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-2023
– volume: 150
  start-page: 1135
  year: 2012
  ident: hep30146-bib-0009-20250401
  article-title: Loss of 5‐hydroxymethylcytosine is an epigenetic hallmark of melanoma
  publication-title: Cell
  doi: 10.1016/j.cell.2012.07.033
– volume: 22
  start-page: 656
  year: 2015
  ident: hep30146-bib-0014-20250401
  article-title: Charting oxidized methylcytosines at base resolution
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.3071
– volume: 32
  start-page: 896
  year: 2014
  ident: hep30146-bib-0043-20250401
  article-title: Normalization of RNA‐seq data using factor analysis of control genes or samples
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2931
– volume: 19
  start-page: 17
  year: 2011
  ident: hep30146-bib-0041-20250401
  article-title: Oncometabolite 2‐hydroxyglutarate is a competitive inhibitor of alpha‐ketoglutarate‐dependent dioxygenases
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.12.014
– volume: 19
  start-page: 831
  year: 2012
  ident: hep30146-bib-0022-20250401
  article-title: 5‐Formylcytosine and 5‐carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.2346
– volume: 333
  start-page: 1303
  year: 2011
  ident: hep30146-bib-0010-20250401
  article-title: Tet‐mediated formation of 5‐carboxylcytosine and its excision by TDG in mammalian DNA
  publication-title: Science
  doi: 10.1126/science.1210944
– volume: 156
  start-page: 45
  year: 2014
  ident: hep30146-bib-0004-20250401
  article-title: Reversing DNA methylation: mechanisms, genomics, and biological functions
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.019
– volume: 14
  start-page: R119
  year: 2013
  ident: hep30146-bib-0019-20250401
  article-title: A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation
  publication-title: Genome Biol
  doi: 10.1186/gb-2013-14-10-r119
– volume: 30
  start-page: 733
  year: 2016
  ident: hep30146-bib-0007-20250401
  article-title: Role of TET enzymes in DNA methylation, development, and cancer
  publication-title: Genes Dev
  doi: 10.1101/gad.276568.115
– volume: 333
  start-page: 1300
  year: 2011
  ident: hep30146-bib-0011-20250401
  article-title: Tet proteins can convert 5‐methylcytosine to 5‐formylcytosine and 5‐carboxylcytosine
  publication-title: Science
  doi: 10.1126/science.1210597
– volume: 6
  start-page: 1049
  year: 2014
  ident: hep30146-bib-0015-20250401
  article-title: 5‐Hydroxymethylcytosine is a predominantly stable DNA modification
  publication-title: Nat Chem
  doi: 10.1038/nchem.2064
– volume: 150
  start-page: 835
  year: 2016
  ident: hep30146-bib-0023-20250401
  article-title: Evidence‐based diagnosis, staging, and treatment of patients with hepatocellular carcinoma
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.12.041
– volume: 62
  start-page: 496
  year: 2015
  ident: hep30146-bib-0035-20250401
  article-title: Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate
  publication-title: Hepatology
  doi: 10.1002/hep.27823
– volume: 62
  start-page: 1190
  year: 2015
  ident: hep30146-bib-0026-20250401
  article-title: World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.27969
– volume: 4
  start-page: 229
  year: 2009
  ident: hep30146-bib-0002-20250401
  article-title: Epigenetic changes in cancer
  publication-title: Annu Rev Pathol
  doi: 10.1146/annurev.pathol.3.121806.151442
– volume: 24
  start-page: 1017
  year: 2014
  ident: hep30146-bib-0040-20250401
  article-title: TET‐catalyzed 5‐methylcytosine hydroxylation is dynamically regulated by metabolites
  publication-title: Cell Res
  doi: 10.1038/cr.2014.81
– volume: 10
  start-page: 61
  year: 2017
  ident: hep30146-bib-0042-20250401
  article-title: Uncoordinated expression of DNA methylation–related enzymes in human cancer
  publication-title: Epigenetics Chromatin
  doi: 10.1186/s13072-017-0170-0
SSID ssj0009428
Score 2.5462794
Snippet Methylation of the fifth position of cytosine (5mC) is an important epigenetic modification of DNA. It has been shown that the oxidized derivatives of 5mC,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 196
SubjectTerms 5-Methylcytosine - analogs & derivatives
5-Methylcytosine - analysis
Carcinoma, Hepatocellular - chemistry
Carcinoma, Hepatocellular - pathology
Cytosine
Cytosine - analogs & derivatives
Cytosine - analysis
Deoxyribonucleic acid
DNA
DNA methylation
DNA, Neoplasm - analysis
Enzymatic activity
Enzymes
Female
Genomes
Hepatitis B
Hepatocellular carcinoma
Hepatology
Humans
Ketoglutaric acid
Liver cancer
Liver Neoplasms - chemistry
Liver Neoplasms - pathology
Male
Middle Aged
Neoplasm Staging
Title Global DNA 5‐Hydroxymethylcytosine and 5‐Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.30146
https://www.ncbi.nlm.nih.gov/pubmed/30070373
https://www.proquest.com/docview/2164425938
https://www.proquest.com/docview/2082092407
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDohLy6OPBYpM1UMvgSTOYy1OiN1VVAlUVUXiUCnyK6UqTSo2e9ieyj_gN_JLOuM8lqWtVPUWxZPEsT2eb-zxNwBv4lAbQ25J6Gvfi8xQeIoHkWfQeihlErSYLtriPMkuoneX8eUKHHdnYRp-iH7BjTTDzdek4FJNjxakoVcWHXaiPsH5l2K1CBB9WFBHicjlVUWvy6fdZdGxCvnhUf_ksi36DWAu41VncCZP4VNX1SbO5OvhrFaH-scjFsf__JcNeNICUXbSjJxNWLHlFqydtVvt23DbZANgo_MTFt__vMvmhmpCGafn13peVxQwz2RpXOkEoe-D247zqqyn-HrLRg6ZTq1hX0qGeJM5UmWGMPezZVXBMrSIdUU7CBQSy04pu1FZfZPP4GIy_niaeW2-Bk9HqMherLgtuOJpEaBBTEQap6ZIVIGD1SgR40Q6lJwbFUY81FqEfipskvgIkKS1QVHw57BaVqV9CUzKIOUGwUpk0IWLEmkCXUiLtjNQdLJxAG-7nst1S2ZOOTWu84aGOcyxSXPXpAN43Yt-bxg8_iS013V_3irxNA_RlcQpTfDhAA76YlQ_ahFZ2mqGMgShBLnFA3jRDJv-K5y4lHjKsbKu8__--Twbv3cXO_8uugvrCN5Esxy0B6v1zcy-QoBUq32nCb8AtjMNQA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkEv5dEHWwqYikMvaZM4j7XEpWq7SqFdoaqVekGRXwFESapu9rCc4B_wG_klzDiPUkolxC2KJ4ljezzf2ONvAF7FoTaG3JLQ174XmaHwFA8iz6D1UMokaDFdtMU4yU6jN2fx2Ry87s7CNPwQ_YIbaYabr0nBaUF6-4o19KNFj524T-7AXcro7Ryq4yvyKBG5zKrod_m0vyw6XiE_3O4fvW6NbkDM64jVmZzRA3jfVbaJNPm8Na3Vlv76B4_j__7NQ1hssSjbaQbPI5iz5WO4d9Tuti_B9yYhANsb77D457cf2cxQVSjp9Oxcz-qKYuaZLI0rHSH6_e22o70q6wm-3rI9B04n1rBPJUPIyRyvMkOk-8GyqmAZGsW6ok0Eioplu5TgqKy-yGU4He2f7GZem7LB0xHqshcrbguueFoEaBMTkcapKRJV4Hg1SsQ4lw4l50aFEQ-1FqGfCpskPmIkaW1QFHwF5suqtE-ASRmk3CBeiQx6cVEiTaALadF8BooONw5gs-u6XLd85pRW4zxvmJjDHJs0d006gI1e9KIh8fib0HrX_3mrx5M8RG8SZzXBhwN42RejBlKLyNJWU5QhFCXIMx7AajNu-q9wolPiKcfKut6__fN5tv_OXaz9u-gLuJ-dHB3mhwfjt09hAbGcaFaH1mG-vpzaZ4iXavXcqcUvcqYRWw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcypsuFDCIA5e0Sewka_VUdbsKr1WFqNQDUmTHNq0oScVmD8sJ_gG_sb-EGedRykNC3KLYSRx7xvONPf4G4FkSl8aQWxKHZRgIM5aB5pEIDFoPrU2KFtNHW8zS_FC8PEqOVmCnPwvT8kMMC26kGX6-JgU_M277gjT02KLDTtQnV-CqSMMxifTk7QV3lBQ-sSq6XSFtL8ueViiMt4dHLxuj3xDmZcDqLc70Orzv29oGmnzcWjR6q_zyC43jf_7MDVjvkCjbbUXnJqzY6hasven22m_DtzYdAJvMdlly_vV7vjTUEko5vTwtl01NEfNMVcaXThH7_nTbk15VzRxfb9nEQ9O5NeykYgg4mWdVZohzP1hWO5ajSWxq2kKgmFi2R-mNqvqTugOH0_13e3nQJWwISoGaHCSaW8c1z1yEFjGVWZIZl2qH0mq0THAmHSvOjY4Fj8tSxmEmbZqGiJCUtZFz_C6sVnVlN4ApFWXcIFoRBn04kSoTlU5ZNJ6RpqONI3jej1xRdmzmlFTjtGh5mOMCu7TwXTqCp0PVs5bC40-VNvvhLzotnhcx-pI4p0k-HsGToRj1j3pEVbZeYB3CUJL84hHca8Vm-AonMiWecWysH_y_f77I9w_8xf1_r_oY1g4m0-L1i9mrB3ANgZxsl4Y2YbX5vLAPESw1-pFXih9WYhAT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+DNA+5-Hydroxymethylcytosine+and+5-Formylcytosine+Contents+Are+Decreased+in+the+Early+Stage+of+Hepatocellular+Carcinoma&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Liu%2C+Jiao&rft.au=Jiang%2C+Jinhua&rft.au=Mo%2C+Jiezhen&rft.au=Liu%2C+Dan&rft.date=2019-01-01&rft.issn=1527-3350&rft.eissn=1527-3350&rft.volume=69&rft.issue=1&rft.spage=196&rft_id=info:doi/10.1002%2Fhep.30146&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon